Adrenergics + anticholinergics
Adrenergics + anticholinergics has been studied in 1 paper since 2022: 1 observational study in people. The newest paper, Aug 29, 2022: “Identifying Protective Drugs for Parkinson's Disease in Health-Care Databases Using Machine Learning”.
1 paper studies it1 findingUpdated
See all 1 papers on adrenergics + anticholinergics
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Other signals included adrenergics in combination with anticholinergics (R03AL) and insulins and analogues (A10AD).”
- 1 lab in 1 country
- Funders: The Michael J. Fox Foundation for Parkinson's Research and 1 more
- Humans1
What is adrenergics + anticholinergics linked with?
1Studies link adrenergics + anticholinergics with Parkinson's disease risk.
Parkinson's disease risk
downin humans1
1 study
Parkinson's disease risk
downin humans1
Adrenergics + anticholinergics are associated with Parkinson's disease risk in humans.
“Other signals included adrenergics in combination with anticholinergics (R03AL) and insulins and analogues (A10AD).”
Humans2-year exposure period starting 10 years before the index date
Identifying Protective Drugs for Parkinson's Disease in Health-Care Databases Using Machine Learning
Movement disorders : official journal of the Movement Disorder Society